Suchin Parihar

Array ( [id] => 11106205 [patent_doc_number] => 20160303175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'Cancer Treatment Using Viruses and Camptothecins' [patent_app_type] => utility [patent_app_number] => 15/195200 [patent_app_country] => US [patent_app_date] => 2016-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2907 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15195200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11350618 [patent_doc_number] => 20160369357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'METHOD FOR DIAGNOSING, QUANTIFYING, TREATING, MONITORING OR EVALUATING CONDITIONS, DISEASES OR DISORDERS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS (HPV) INFECTION' [patent_app_type] => utility [patent_app_number] => 15/189811 [patent_app_country] => US [patent_app_date] => 2016-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11689 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15189811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15978013 [patent_doc_number] => 10669315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-02 [patent_title] => HPV vaccines [patent_app_type] => utility [patent_app_number] => 15/580964 [patent_app_country] => US [patent_app_date] => 2016-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 41 [patent_no_of_words] => 64282 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11625930 [patent_doc_number] => 20170136118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-18 [patent_title] => 'NEUTRALIZING MOLECULES TO VIRAL ANTIGENS' [patent_app_type] => utility [patent_app_number] => 15/177232 [patent_app_country] => US [patent_app_date] => 2016-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 35045 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15177232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11310250 [patent_doc_number] => 20160346360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR CELL TARGETED HPV TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/166936 [patent_app_country] => US [patent_app_date] => 2016-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 16790 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15166936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12770836 [patent_doc_number] => 20180148780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => Next-Generation Sequencing-Based Genotyping Assay for Human Papilloma Virus (HPV) [patent_app_type] => utility [patent_app_number] => 15/575977 [patent_app_country] => US [patent_app_date] => 2016-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13270 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12580860 [patent_doc_number] => 20180085449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => ANTI-MYCOBACTERIUM TUBERCULOSIS VACCINE USING SENDAI VIRUS AS VECTOR [patent_app_type] => utility [patent_app_number] => 15/568117 [patent_app_country] => US [patent_app_date] => 2016-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12675919 [patent_doc_number] => 20180117139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => IMMUNE COMPLEX [patent_app_type] => utility [patent_app_number] => 15/560074 [patent_app_country] => US [patent_app_date] => 2016-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12239935 [patent_doc_number] => 20180072798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'A SEROTYPE CROSS-REACTIVE, DENGUE NEUTRALIZING ANTIBODY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/558937 [patent_app_country] => US [patent_app_date] => 2016-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15637 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14420239 [patent_doc_number] => 10314906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-11 [patent_title] => Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease [patent_app_type] => utility [patent_app_number] => 15/558942 [patent_app_country] => US [patent_app_date] => 2016-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 88 [patent_no_of_words] => 15908 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003827 [patent_doc_number] => 20160200776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'Truncated L1 Protein of Human Papillomavirus Type 58' [patent_app_type] => utility [patent_app_number] => 15/057416 [patent_app_country] => US [patent_app_date] => 2016-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11200 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10997716 [patent_doc_number] => 20160194662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'RECOMBINANT VIRUS-LIKE PARTICLES ENCODED BY MULTI-GENE VECTOR' [patent_app_type] => utility [patent_app_number] => 15/054625 [patent_app_country] => US [patent_app_date] => 2016-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6837 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12233375 [patent_doc_number] => 20180066238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'LIVE ATTENUATED VACCINES FOR PNEUMOVIRUSES AND RELATED METHODS AND MATERIALS' [patent_app_type] => utility [patent_app_number] => 15/552212 [patent_app_country] => US [patent_app_date] => 2016-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13724 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12657052 [patent_doc_number] => 20180110850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => IMMUNOGENIC RSV POLYPEPTIDES [patent_app_type] => utility [patent_app_number] => 15/562862 [patent_app_country] => US [patent_app_date] => 2016-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15038 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15562862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16026373 [patent_doc_number] => 10675588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Method of purifying a biological material of interest in a sample using nanofiber ultrafiltration membranes operated in tangential flow filtration mode [patent_app_type] => utility [patent_app_number] => 15/561579 [patent_app_country] => US [patent_app_date] => 2016-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 33 [patent_no_of_words] => 13034 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16405422 [patent_doc_number] => 10813959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Cancer therapy with a parvovirus combined with bevacizumab [patent_app_type] => utility [patent_app_number] => 15/550354 [patent_app_country] => US [patent_app_date] => 2016-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4280 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12641247 [patent_doc_number] => 20180105580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-19 [patent_title] => FILOVIRUS THERAPY [patent_app_type] => utility [patent_app_number] => 15/549933 [patent_app_country] => US [patent_app_date] => 2016-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119671 [patent_doc_number] => 10246685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Recombinant MDV1 and the uses thereof [patent_app_type] => utility [patent_app_number] => 15/547737 [patent_app_country] => US [patent_app_date] => 2016-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9100 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10790109 [patent_doc_number] => 20160136265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR VIRAL IMMUNOTHERAPY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/007160 [patent_app_country] => US [patent_app_date] => 2016-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12598 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15007160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14294875 [patent_doc_number] => 10287555 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-14 [patent_title] => Rotavirus-like particle production in plants [patent_app_type] => utility [patent_app_number] => 15/545362 [patent_app_country] => US [patent_app_date] => 2016-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 61 [patent_no_of_words] => 41432 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545362 [rel_patent_id] =>[rel_patent_doc_number] =>)